Zevra Therapeutics, Inc.ZVRANASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank85
3Y CAGR-1.6%
5Y CAGR+71.4%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-1.6%/yr
vs +37.3%/yr prior
5Y CAGR
+71.4%/yr
Recent deceleration
Acceleration
-38.9pp
Decelerating
Percentile
P85
Within normal range
vs 5Y Ago
14.8x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $62.41M | +84.7% |
| 2024 | $33.78M | -21.5% |
| 2023 | $43.05M | -34.2% |
| 2022 | $65.47M | -41.7% |
| 2021 | $112.35M | +2566.7% |
| 2020 | $4.21M | +31.0% |
| 2019 | $3.22M | -82.5% |
| 2018 | $18.41M | +69.3% |
| 2017 | $10.87M | -35.1% |
| 2016 | $16.76M | - |